Die postoperative prognose des chromophoben nierenzellkarzinoms. Eine vergleichende analyse anhand der multinationalen CORONA-datenbank

M. May; R. Zigeuner; A. Aziz; L. Cindolo; C. Gilfrich; L. Schips; O. De Cobelli; B. Rocco; C. De Nunzio; A. Tubaro; I. Coman; B. Feciche; M. Truss; B. Hoschke; O. Dalpiaz; A. Stoltze; F. Fenske; H. M. Fritsche; T. Chromecki; S. Lebentrau; R. S. Figenshau; K. Madison; M. Sánchez-Chapado; M. Del Carmen Santiago Martin; L. Salzano; G. Lotrecchiano; S. Joniau; R. Waidelich; C. G. Stief; S. Brookman-May

doi:10.1007/s00120-013-3237-y

Die postoperative prognose des chromophoben nierenzellkarzinoms. Eine vergleichende analyse anhand der multinationalen CORONA-datenbank

Translated title of the contribution: Postoperative prognosis of chromophobic renal cell carcinoma. Comparative analysis of the multinational CORONA database

M. May, R. Zigeuner, A. Aziz, L. Cindolo, C. Gilfrich, L. Schips, O. De Cobelli, B. Rocco, C. De Nunzio, A. Tubaro, I. Coman, B. Feciche, M. Truss, B. Hoschke, O. Dalpiaz, A. Stoltze, F. Fenske, H. M. Fritsche, T. Chromecki, S. LebentrauR. S. Figenshau, K. Madison, M. Sánchez-Chapado, M. Del Carmen Santiago Martin, L. Salzano, G. Lotrecchiano, S. Joniau, R. Waidelich, C. G. Stief, S. Brookman-May

Research output: Contribution to journal › Article › peer-review

Abstract

Background. The chromophobe subtype represents the third most common histological subtype of renal cell carcinoma (chRCC). Due to the rarity of this subtype only one publication regarding the specific analysis of clinical and histopathological criteria as well as survival analysis of more than 200 patients with chRCC is known to date. Materials and methods. A total of 6,234 RCC patients from 11 centres who were treated by (partial) nephrectomy are contained in the database of this multinational study. Of the patients 259 were diagnosed with chRCC (4.2%) and thus formed the study group for this retrospective investigation. These subjects were compared to 4,994 patients with a clear cell subtype (80.1%) with respect to clinical and histopathological criteria. The independent influence of the chromophobe subtype regarding tumor-specific survival and overall survival was determined using analysis by Cox proportional hazards regression models. The median follow-up was 59 months (interquartile range 29-106 months). Results. The chRCC patients were significantly younger (60 vs. 63.2 years, p

Translated title of the contribution	Postoperative prognosis of chromophobic renal cell carcinoma. Comparative analysis of the multinational CORONA database
Original language	German
Pages (from-to)	228-235
Number of pages	8
Journal	Urologe - Ausgabe A
Volume	53
Issue number	2
DOIs	https://doi.org/10.1007/s00120-013-3237-y
Publication status	Published - 2014

Keywords

Cox regression analysis
Gender
Nephrectomy
Survival
Tumor

ASJC Scopus subject areas

Urology

Access to Document

10.1007/s00120-013-3237-y

Fingerprint Dive into the research topics of 'Postoperative prognosis of chromophobic renal cell carcinoma. Comparative analysis of the multinational CORONA database'. Together they form a unique fingerprint.

Cite this

May, M., Zigeuner, R., Aziz, A., Cindolo, L., Gilfrich, C., Schips, L., De Cobelli, O., Rocco, B., De Nunzio, C., Tubaro, A., Coman, I., Feciche, B., Truss, M., Hoschke, B., Dalpiaz, O., Stoltze, A., Fenske, F., Fritsche, H. M., Chromecki, T., ... Brookman-May, S. (2014). Die postoperative prognose des chromophoben nierenzellkarzinoms. Eine vergleichende analyse anhand der multinationalen CORONA-datenbank. Urologe - Ausgabe A, 53(2), 228-235. https://doi.org/10.1007/s00120-013-3237-y

Die postoperative prognose des chromophoben nierenzellkarzinoms. Eine vergleichende analyse anhand der multinationalen CORONA-datenbank. / May, M.; Zigeuner, R.; Aziz, A.; Cindolo, L.; Gilfrich, C.; Schips, L.; De Cobelli, O.; Rocco, B.; De Nunzio, C.; Tubaro, A.; Coman, I.; Feciche, B.; Truss, M.; Hoschke, B.; Dalpiaz, O.; Stoltze, A.; Fenske, F.; Fritsche, H. M.; Chromecki, T.; Lebentrau, S.; Figenshau, R. S.; Madison, K.; Sánchez-Chapado, M.; Del Carmen Santiago Martin, M.; Salzano, L.; Lotrecchiano, G.; Joniau, S.; Waidelich, R.; Stief, C. G.; Brookman-May, S.

In: Urologe - Ausgabe A, Vol. 53, No. 2, 2014, p. 228-235.

Research output: Contribution to journal › Article › peer-review

May, M, Zigeuner, R, Aziz, A, Cindolo, L, Gilfrich, C, Schips, L, De Cobelli, O, Rocco, B, De Nunzio, C, Tubaro, A, Coman, I, Feciche, B, Truss, M, Hoschke, B, Dalpiaz, O, Stoltze, A, Fenske, F, Fritsche, HM, Chromecki, T, Lebentrau, S, Figenshau, RS, Madison, K, Sánchez-Chapado, M, Del Carmen Santiago Martin, M, Salzano, L, Lotrecchiano, G, Joniau, S, Waidelich, R, Stief, CG & Brookman-May, S 2014, 'Die postoperative prognose des chromophoben nierenzellkarzinoms. Eine vergleichende analyse anhand der multinationalen CORONA-datenbank', Urologe - Ausgabe A, vol. 53, no. 2, pp. 228-235. https://doi.org/10.1007/s00120-013-3237-y

May, M. ; Zigeuner, R. ; Aziz, A. ; Cindolo, L. ; Gilfrich, C. ; Schips, L. ; De Cobelli, O. ; Rocco, B. ; De Nunzio, C. ; Tubaro, A. ; Coman, I. ; Feciche, B. ; Truss, M. ; Hoschke, B. ; Dalpiaz, O. ; Stoltze, A. ; Fenske, F. ; Fritsche, H. M. ; Chromecki, T. ; Lebentrau, S. ; Figenshau, R. S. ; Madison, K. ; Sánchez-Chapado, M. ; Del Carmen Santiago Martin, M. ; Salzano, L. ; Lotrecchiano, G. ; Joniau, S. ; Waidelich, R. ; Stief, C. G. ; Brookman-May, S. / Die postoperative prognose des chromophoben nierenzellkarzinoms. Eine vergleichende analyse anhand der multinationalen CORONA-datenbank. In: Urologe - Ausgabe A. 2014 ; Vol. 53, No. 2. pp. 228-235.

@article{14e2e13cd1354c87b26169f1da407c4b,

title = "Die postoperative prognose des chromophoben nierenzellkarzinoms. Eine vergleichende analyse anhand der multinationalen CORONA-datenbank",

abstract = "Background. The chromophobe subtype represents the third most common histological subtype of renal cell carcinoma (chRCC). Due to the rarity of this subtype only one publication regarding the specific analysis of clinical and histopathological criteria as well as survival analysis of more than 200 patients with chRCC is known to date. Materials and methods. A total of 6,234 RCC patients from 11 centres who were treated by (partial) nephrectomy are contained in the database of this multinational study. Of the patients 259 were diagnosed with chRCC (4.2%) and thus formed the study group for this retrospective investigation. These subjects were compared to 4,994 patients with a clear cell subtype (80.1%) with respect to clinical and histopathological criteria. The independent influence of the chromophobe subtype regarding tumor-specific survival and overall survival was determined using analysis by Cox proportional hazards regression models. The median follow-up was 59 months (interquartile range 29-106 months). Results. The chRCC patients were significantly younger (60 vs. 63.2 years, p",

keywords = "Cox regression analysis, Gender, Nephrectomy, Survival, Tumor",

author = "M. May and R. Zigeuner and A. Aziz and L. Cindolo and C. Gilfrich and L. Schips and {De Cobelli}, O. and B. Rocco and {De Nunzio}, C. and A. Tubaro and I. Coman and B. Feciche and M. Truss and B. Hoschke and O. Dalpiaz and A. Stoltze and F. Fenske and Fritsche, {H. M.} and T. Chromecki and S. Lebentrau and Figenshau, {R. S.} and K. Madison and M. S{\'a}nchez-Chapado and {Del Carmen Santiago Martin}, M. and L. Salzano and G. Lotrecchiano and S. Joniau and R. Waidelich and Stief, {C. G.} and S. Brookman-May",

year = "2014",

doi = "10.1007/s00120-013-3237-y",

language = "Tedesco",

volume = "53",

pages = "228--235",

journal = "Der Urologe",

issn = "0340-2592",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - Die postoperative prognose des chromophoben nierenzellkarzinoms. Eine vergleichende analyse anhand der multinationalen CORONA-datenbank

AU - May, M.

AU - Zigeuner, R.

AU - Aziz, A.

AU - Cindolo, L.

AU - Gilfrich, C.

AU - Schips, L.

AU - De Cobelli, O.

AU - Rocco, B.

AU - De Nunzio, C.

AU - Tubaro, A.

AU - Coman, I.

AU - Feciche, B.

AU - Truss, M.

AU - Hoschke, B.

AU - Dalpiaz, O.

AU - Stoltze, A.

AU - Fenske, F.

AU - Fritsche, H. M.

AU - Chromecki, T.

AU - Lebentrau, S.

AU - Figenshau, R. S.

AU - Madison, K.

AU - Sánchez-Chapado, M.

AU - Del Carmen Santiago Martin, M.

AU - Salzano, L.

AU - Lotrecchiano, G.

AU - Joniau, S.

AU - Waidelich, R.

AU - Stief, C. G.

AU - Brookman-May, S.

PY - 2014

Y1 - 2014

N2 - Background. The chromophobe subtype represents the third most common histological subtype of renal cell carcinoma (chRCC). Due to the rarity of this subtype only one publication regarding the specific analysis of clinical and histopathological criteria as well as survival analysis of more than 200 patients with chRCC is known to date. Materials and methods. A total of 6,234 RCC patients from 11 centres who were treated by (partial) nephrectomy are contained in the database of this multinational study. Of the patients 259 were diagnosed with chRCC (4.2%) and thus formed the study group for this retrospective investigation. These subjects were compared to 4,994 patients with a clear cell subtype (80.1%) with respect to clinical and histopathological criteria. The independent influence of the chromophobe subtype regarding tumor-specific survival and overall survival was determined using analysis by Cox proportional hazards regression models. The median follow-up was 59 months (interquartile range 29-106 months). Results. The chRCC patients were significantly younger (60 vs. 63.2 years, p

AB - Background. The chromophobe subtype represents the third most common histological subtype of renal cell carcinoma (chRCC). Due to the rarity of this subtype only one publication regarding the specific analysis of clinical and histopathological criteria as well as survival analysis of more than 200 patients with chRCC is known to date. Materials and methods. A total of 6,234 RCC patients from 11 centres who were treated by (partial) nephrectomy are contained in the database of this multinational study. Of the patients 259 were diagnosed with chRCC (4.2%) and thus formed the study group for this retrospective investigation. These subjects were compared to 4,994 patients with a clear cell subtype (80.1%) with respect to clinical and histopathological criteria. The independent influence of the chromophobe subtype regarding tumor-specific survival and overall survival was determined using analysis by Cox proportional hazards regression models. The median follow-up was 59 months (interquartile range 29-106 months). Results. The chRCC patients were significantly younger (60 vs. 63.2 years, p

KW - Cox regression analysis

KW - Gender

KW - Nephrectomy

KW - Survival

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=84898445007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898445007&partnerID=8YFLogxK

U2 - 10.1007/s00120-013-3237-y

DO - 10.1007/s00120-013-3237-y

M3 - Articolo

C2 - 23836364

AN - SCOPUS:84898445007

VL - 53

SP - 228

EP - 235

JO - Der Urologe

JF - Der Urologe

SN - 0340-2592

IS - 2

ER -